179 related articles for article (PubMed ID: 19487641)
1. Poor glycemic control is an independent risk factor for low HDL cholesterol in patients with type 2 diabetes.
Gatti A; Maranghi M; Bacci S; Carallo C; Gnasso A; Mandosi E; Fallarino M; Morano S; Trischitta V; Filetti S
Diabetes Care; 2009 Aug; 32(8):1550-2. PubMed ID: 19487641
[TBL] [Abstract][Full Text] [Related]
2. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
[No Abstract] [Full Text] [Related]
3. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study.
Achila OO; Ghebretinsae M; Kidane A; Simon M; Makonen S; Rezene Y
J Diabetes Res; 2020; 2020():5901569. PubMed ID: 32090121
[TBL] [Abstract][Full Text] [Related]
5. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study.
Selvin E; Coresh J; Golden SH; Boland LL; Brancati FL; Steffes MW;
Diabetes Care; 2005 Aug; 28(8):1965-73. PubMed ID: 16043740
[TBL] [Abstract][Full Text] [Related]
6. log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males.
Hermans MP; Ahn SA; Rousseau MF
Cardiovasc Diabetol; 2010 Dec; 9():88. PubMed ID: 21156040
[TBL] [Abstract][Full Text] [Related]
7. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.
Russo GT; De Cosmo S; Viazzi F; Pacilli A; Ceriello A; Genovese S; Guida P; Giorda C; Cucinotta D; Pontremoli R; Fioretto P;
Diabetes Care; 2016 Dec; 39(12):2278-2287. PubMed ID: 27703024
[TBL] [Abstract][Full Text] [Related]
8. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Orchard TJ; Forrest KY; Kuller LH; Becker DJ;
Diabetes Care; 2001 Jun; 24(6):1053-9. PubMed ID: 11375370
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors.
Du T; Yuan G; Zhou X; Sun X
Ann Med; 2016; 48(1-2):34-41. PubMed ID: 26758477
[TBL] [Abstract][Full Text] [Related]
10. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.
Petitti DB; Imperatore G; Palla SL; Daniels SR; Dolan LM; Kershnar AK; Marcovina S; Pettitt DJ; Pihoker C;
Arch Pediatr Adolesc Med; 2007 Feb; 161(2):159-65. PubMed ID: 17283301
[TBL] [Abstract][Full Text] [Related]
11. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes.
Schulze MB; Shai I; Manson JE; Li T; Rifai N; Jiang R; Hu FB
Diabetologia; 2004 Dec; 47(12):2129-36. PubMed ID: 15662553
[TBL] [Abstract][Full Text] [Related]
12. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
Sharif S; van der Graaf Y; Nathoe HM; de Valk HW; Visseren FL; Westerink J;
Diabetes Care; 2016 Aug; 39(8):1424-30. PubMed ID: 27222511
[TBL] [Abstract][Full Text] [Related]
13. Diabetes Self-Management Education and Medical Nutrition Therapy: A Multisite Study Documenting the Efficacy of Registered Dietitian Nutritionist Interventions in the Management of Glycemic Control and Diabetic Dyslipidemia through Retrospective Chart Review.
Marincic PZ; Salazar MV; Hardin A; Scott S; Fan SX; Gaillard PR; Wyatt C; Watson L; Green P; Glover P; Hand M
J Acad Nutr Diet; 2019 Mar; 119(3):449-463. PubMed ID: 30219311
[TBL] [Abstract][Full Text] [Related]
14. [La educación multimedia como apoyo en el manejo de pacientes con diabetes tipo 2. Estudio cuasi experimental].
Aguila IP; Velázquez-López L; Goycochea-Robles MAV; Angulo-Angulo F; Peña JE
Cir Cir; 2018; 86(5):404-411. PubMed ID: 30226499
[TBL] [Abstract][Full Text] [Related]
15. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.
Erdman DM; Cook CB; Greenlund KJ; Giles WH; El-Kebbi I; Ryan GJ; Gallina DL; Ziemer DC; Dunbar VG; Phillips LS
Diabetes Care; 2002 Jan; 25(1):9-15. PubMed ID: 11772894
[TBL] [Abstract][Full Text] [Related]
16. Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes.
Ganda OP; Arkin CF
Diabetes Care; 1992 Oct; 15(10):1245-50. PubMed ID: 1425083
[TBL] [Abstract][Full Text] [Related]
17. The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population.
Yang P; Hu W; Fu Z; Sun L; Zhou Y; Gong Y; Yang T; Zhou H
Lipids Health Dis; 2016 Jul; 15():120. PubMed ID: 27457614
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
[TBL] [Abstract][Full Text] [Related]
19. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
20. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
Dailey GE; Mohideen P; Fiedorek FT
Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
